UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells

Journal of investigative dermatology, 2019-12, Vol.139 (12), p.2506-2516.e10

2019

Volltextzugriff (PDF)

Cyclophosphamide Promotes Chronic Inflammation–Dependent Immunosuppression and Prevents Antitumor Response in Melanoma

Journal of investigative dermatology, 2013-06, Vol.133 (6), p.1610-1619

2013

Volltextzugriff (PDF)

The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells

Journal of investigative dermatology, 2011-02, Vol.131 (2), p.468-479

2011

Volltextzugriff (PDF)

Peroxisome Proliferator-Activating Receptors: A New Way to Treat Melanoma?

Journal of investigative dermatology, 2009-05, Vol.129 (5), p.1061-1063

Schadendorf, Dirk

2009

Volltextzugriff (PDF)

Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition

Journal of investigative dermatology, 2021-07, Vol.141 (7), p.1675-1686.e4

2021

Volltextzugriff (PDF)

Melanoma Differentiation Trajectories Determine Sensitivity toward Pre-Existing CD8+ Tumor-Infiltrating Lymphocytes

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.2480-2489

2021

Volltextzugriff (PDF)

miR-137 Inhibits the Invasion of Melanoma Cells through Downregulation of Multiple Oncogenic Target Genes

Journal of investigative dermatology, 2013-03, Vol.133 (3), p.768-775

2013

Volltextzugriff (PDF)

Panel Sequencing Melanomas

Journal of investigative dermatology, 2015-02, Vol.135 (2), p.335-336

2015

Volltextzugriff (PDF)

Navtemadlin (KRT-232) in combination with avelumab for patients with anti-PD-1/L1 treatment-naïve TP53 Merkel cell carcinoma (MCC)

Journal of investigative dermatology, 2022-10, Vol.142 (10), p.2841

2022

Volltextzugriff (PDF)

An Animal Model of Cutaneous Cyst Development Enables the Identification of Three Quantitative Trait Loci, Including the Homologue of a Human Locus (TRICY1)

Journal of investigative dermatology, 2019-10, Vol.139 (10), p.2235-2238.e5

2019

Volltextzugriff (PDF)

Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors

Journal of investigative dermatology, 2017-09, Vol.137 (9), p.2033-2035

2017

Volltextzugriff (PDF)

T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma

Journal of investigative dermatology, 2020-11, Vol.140 (11), p.2146-2156.e4

2020

Volltextzugriff (PDF)

Overexpression of cMOAT (MRP2/ABCC2) Is Associated with Decreased Formation of Platinum-DNA Adducts and Decreased G2-Arrest in Melanoma Cells Resistant to Cisplatin

Journal of investigative dermatology, 2003-07, Vol.121 (1), p.172-176

2003

Volltextzugriff (PDF)

Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature

Journal of investigative dermatology, 2016-07, Vol.136 (7), p.1526-1528

2016

Volltextzugriff (PDF)

Association between the Germline MC1R Variants and Somatic BRAF/NRAS Mutations in Melanoma Tumors

Journal of investigative dermatology, 2010-12, Vol.130 (12), p.2844-2848

2010

Volltextzugriff (PDF)

Melanoma differentiation trajectories determine sensitivity towards pre-existing CD8 + tumor-infiltrating lymphocytes

Journal of investigative dermatology, 2021-03

2021

Volltextzugriff (PDF)

ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma

Journal of investigative dermatology, 2011-06, Vol.131 (6), p.1280-1290

2011

Volltextzugriff (PDF)

Functional CCR9 Expression Is Associated with Small Intestinal Metastasis

Journal of investigative dermatology, 2004-03, Vol.122 (3), p.685-690

2004

Volltextzugriff (PDF)

cTAGE: A Cutaneous T Cell Lymphoma Associated Antigen Family with Tumor-Specific Splicing

Journal of investigative dermatology, 2003-07, Vol.121 (1), p.198-206

2003

Volltextzugriff (PDF)

fRCCS p.Asp1104His and ERCC2 p.Lys751 GIn Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma

Journal of investigative dermatology, 2011, Vol.131 (6), p.1280-1290

2011

Volltextzugriff (PDF)

Role of Apaf-1 in Melanoma Drug Resistance and Apoptosis

Journal of general internal medicine : JGIM, 2005-08, Vol.125 (2), p.386-387, Article 386

2005

Volltextzugriff (PDF)

GBP-5 Splicing Variants: New Guanylate-Binding Proteins with Tumor-Associated Expression and Antigenicity

Journal of investigative dermatology, 2004-06, Vol.122 (6), p.1510-1517

2004

Volltextzugriff (PDF)

Drug Resistance Towards Etoposide and Cisplatin in Human Melanoma Cells is Associated with Drug-Dependent Apoptosis Deficiency

Journal of investigative dermatology, 2002-06, Vol.118 (6), p.923-932

2002

Volltextzugriff (PDF)

Alterations of DNA Repair in Melanoma Cell Lines Resistant to Cisplatin, Fotemustine, or Etoposide

Journal of investigative dermatology, 2000-01, Vol.114 (1), p.34-39

2000

Volltextzugriff (PDF)

The Use of Histamine in Cancer Immunotherapy

Journal of investigative dermatology, 2002-03, Vol.118 (3), p.560-561

2002

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Investigative Dermatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Dermatology
(25)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(22)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Melanoma - Pathology
(8)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(8)
Antineoplastic Agents - Pharmacology
(6)
Melanoma - Genetics
(6)
Skin Neoplasms - Pathology
(6)
Melanoma
(5)
Melanoma - Metabolism
(5)
Adult
(4)
Aged
(4)
Female
(4)
Male
(4)
Middle Aged
(4)
Skin Neoplasms - Genetics
(4)
Apoptosis - Drug Effects
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells

Cyclophosphamide Promotes Chronic Inflammation–Dependent Immunosuppression and Prevents Antitumor Response in Melanoma

The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells

Peroxisome Proliferator-Activating Receptors: A New Way to Treat Melanoma?

Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition

Melanoma Differentiation Trajectories Determine Sensitivity toward Pre-Existing CD8+ Tumor-Infiltrating Lymphocytes

miR-137 Inhibits the Invasion of Melanoma Cells through Downregulation of Multiple Oncogenic Target Genes

Panel Sequencing Melanomas

Navtemadlin (KRT-232) in combination with avelumab for patients with anti-PD-1/L1 treatment-naïve TP53 Merkel cell carcinoma (MCC)

An Animal Model of Cutaneous Cyst Development Enables the Identification of Three Quantitative Trait Loci, Including the Homologue of a Human Locus (TRICY1)

Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors

T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma

Overexpression of cMOAT (MRP2/ABCC2) Is Associated with Decreased Formation of Platinum-DNA Adducts and Decreased G2-Arrest in Melanoma Cells Resistant to Cisplatin

Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature

Association between the Germline MC1R Variants and Somatic BRAF/NRAS Mutations in Melanoma Tumors

Melanoma differentiation trajectories determine sensitivity towards pre-existing CD8 + tumor-infiltrating lymphocytes

ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma

Functional CCR9 Expression Is Associated with Small Intestinal Metastasis

cTAGE: A Cutaneous T Cell Lymphoma Associated Antigen Family with Tumor-Specific Splicing

fRCCS p.Asp1104His and ERCC2 p.Lys751 GIn Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma

Role of Apaf-1 in Melanoma Drug Resistance and Apoptosis

GBP-5 Splicing Variants: New Guanylate-Binding Proteins with Tumor-Associated Expression and Antigenicity

Drug Resistance Towards Etoposide and Cisplatin in Human Melanoma Cells is Associated with Drug-Dependent Apoptosis Deficiency

Alterations of DNA Repair in Melanoma Cell Lines Resistant to Cisplatin, Fotemustine, or Etoposide

The Use of Histamine in Cancer Immunotherapy

Aktive Filter

Suchergebnisse filtern